P I Industries Ltd
PI Industries Ltd is a leading player in the agro-chemicals space having strong presence in both Domestic and Export markets. It has state-of-art facilities in Gujarat having integrated process development teams with in-house engineering capabilities.[1]
- Market Cap ₹ 57,217 Cr.
- Current Price ₹ 3,771
- High / Low ₹ 4,040 / 3,060
- Stock P/E 35.2
- Book Value ₹ 520
- Dividend Yield 0.27 %
- ROCE 21.7 %
- ROE 18.4 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 27.4% CAGR over last 5 years
- Company's median sales growth is 16.4% of last 10 years
Cons
- Stock is trading at 7.26 times its book value
- Tax rate seems low
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
877 | 1,151 | 1,595 | 1,940 | 2,096 | 2,276 | 2,277 | 2,841 | 3,307 | 4,361 | 5,077 | 6,270 | 7,026 | |
764 | 969 | 1,303 | 1,560 | 1,663 | 1,724 | 1,782 | 2,264 | 2,606 | 3,370 | 3,962 | 4,748 | 5,118 | |
Operating Profit | 114 | 182 | 292 | 379 | 433 | 552 | 495 | 576 | 701 | 991 | 1,114 | 1,522 | 1,907 |
OPM % | 13% | 16% | 18% | 20% | 21% | 24% | 22% | 20% | 21% | 23% | 22% | 24% | 27% |
65 | 8 | 11 | 34 | 33 | 36 | 60 | 59 | 47 | 117 | 100 | 159 | 221 | |
Interest | 22 | 24 | 14 | 12 | 12 | 9 | 8 | 8 | 20 | 34 | 15 | 38 | 8 |
Depreciation | 17 | 22 | 31 | 49 | 54 | 73 | 83 | 93 | 133 | 172 | 198 | 222 | 240 |
Profit before tax | 139 | 144 | 258 | 353 | 401 | 506 | 464 | 535 | 594 | 902 | 1,000 | 1,422 | 1,880 |
Tax % | 28% | 33% | 29% | 31% | 23% | 10% | 21% | 24% | 26% | 21% | 18% | 15% | |
101 | 96 | 184 | 243 | 310 | 457 | 367 | 408 | 442 | 710 | 820 | 1,211 | 1,626 | |
EPS in Rs | 8.03 | 7.11 | 13.50 | 17.81 | 22.58 | 33.24 | 26.58 | 29.54 | 32.03 | 46.83 | 54.03 | 79.85 | 107.16 |
Dividend Payout % | 12% | 14% | 15% | 14% | 14% | 12% | 15% | 14% | 12% | 11% | 11% | 13% |
Compounded Sales Growth | |
---|---|
10 Years: | 18% |
5 Years: | 22% |
3 Years: | 24% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 29% |
5 Years: | 27% |
3 Years: | 40% |
TTM: | 43% |
Stock Price CAGR | |
---|---|
10 Years: | 31% |
5 Years: | 29% |
3 Years: | 14% |
1 Year: | 11% |
Return on Equity | |
---|---|
10 Years: | 20% |
5 Years: | 17% |
3 Years: | 17% |
Last Year: | 18% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 13 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 15 | 15 | 15 | 15 |
Reserves | 307 | 511 | 669 | 869 | 1,141 | 1,595 | 1,898 | 2,261 | 2,577 | 5,271 | 6,024 | 7,082 | 7,868 |
249 | 217 | 122 | 115 | 151 | 120 | 84 | 49 | 519 | 370 | 305 | 33 | 37 | |
228 | 387 | 504 | 624 | 629 | 554 | 619 | 821 | 997 | 1,308 | 1,285 | 1,206 | 1,625 | |
Total Liabilities | 797 | 1,129 | 1,309 | 1,621 | 1,935 | 2,283 | 2,615 | 3,145 | 4,106 | 6,965 | 7,628 | 8,336 | 9,545 |
294 | 475 | 524 | 530 | 872 | 943 | 996 | 1,184 | 1,668 | 2,118 | 2,423 | 2,513 | 2,577 | |
CWIP | 81 | 61 | 42 | 133 | 71 | 77 | 90 | 183 | 270 | 288 | 114 | 130 | 159 |
Investments | 2 | 2 | 2 | 2 | 1 | 84 | 161 | 123 | 454 | 1,012 | 1,036 | 1,169 | 1,746 |
420 | 591 | 741 | 956 | 990 | 1,179 | 1,368 | 1,655 | 1,715 | 3,548 | 4,055 | 4,524 | 5,063 | |
Total Assets | 797 | 1,129 | 1,309 | 1,621 | 1,935 | 2,283 | 2,615 | 3,145 | 4,106 | 6,965 | 7,628 | 8,336 | 9,545 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
101 | 103 | 217 | 181 | 366 | 337 | 314 | 385 | 661 | 772 | 485 | 1,502 | |
-105 | -145 | -51 | -146 | -298 | -236 | -182 | -320 | -962 | -2,470 | -104 | -576 | |
4 | 42 | -142 | -50 | -48 | -50 | -100 | -122 | 350 | 1,689 | -175 | -430 | |
Net Cash Flow | -0 | 0 | 24 | -16 | 20 | 50 | 32 | -56 | 49 | -9 | 207 | 495 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 72 | 83 | 59 | 72 | 69 | 68 | 84 | 85 | 61 | 54 | 57 | 40 |
Inventory Days | 142 | 131 | 127 | 130 | 124 | 136 | 141 | 126 | 145 | 152 | 175 | 144 |
Days Payable | 76 | 131 | 116 | 122 | 115 | 90 | 116 | 121 | 112 | 118 | 116 | 89 |
Cash Conversion Cycle | 137 | 84 | 69 | 80 | 78 | 113 | 110 | 90 | 94 | 89 | 116 | 95 |
Working Capital Days | 79 | 69 | 49 | 55 | 54 | 72 | 89 | 92 | 71 | 73 | 98 | 67 |
ROCE % | 26% | 26% | 36% | 41% | 36% | 34% | 25% | 25% | 23% | 21% | 17% | 22% |
Documents
Announcements
- Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 20 Apr
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 20 Apr
- Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 20 Apr
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 20 Apr
- Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended March 31, 2024 13 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Feb 2024Transcript PPT REC
-
Nov 2023TranscriptPPT
-
Nov 2023Transcript PPT REC
-
Aug 2023TranscriptPPT
-
Aug 2023Transcript PPT
-
Jun 2023TranscriptNotesPPT
-
May 2023Transcript PPT
-
May 2023TranscriptPPT
-
Feb 2023TranscriptPPT
-
Nov 2022TranscriptPPT
-
Aug 2022Transcript PPT
-
May 2022TranscriptPPT
-
Feb 2022TranscriptPPT
-
Nov 2021TranscriptPPT
-
Aug 2021Transcript PPT
-
May 2021TranscriptPPT
-
Jan 2021TranscriptPPT
-
Oct 2020TranscriptPPT
-
Jul 2020TranscriptPPT
-
Jun 2020TranscriptPPT
-
Feb 2020TranscriptPPT
-
Oct 2019TranscriptPPT
-
Jul 2019TranscriptPPT
-
May 2019TranscriptPPT
-
Feb 2019TranscriptPPT
-
Oct 2018TranscriptPPT
-
Aug 2018TranscriptPPT
-
Jun 2018Transcript PPT
-
Feb 2018TranscriptPPT
-
Oct 2017TranscriptPPT
-
Aug 2017TranscriptPPT
-
May 2017TranscriptPPT
-
Feb 2017TranscriptPPT
-
Oct 2016TranscriptPPT
-
Jul 2016TranscriptPPT
Revenue Breakup
Its revenues are divided under 2 main categories. It earns ~76% of its revenues from active ingredients and intermediaries and ~23% of revenues from sale of formulations.[1]